Sawai acquires Upsher-Smith's generic business for $1.1bn

21-04-2017

Sawai acquires Upsher-Smith's generic business for $1.1bn

in-focus / iStockphoto.com

Japan-based Sawai Pharmaceutical has agreed to buy the generic drugs business of Upsher-Smith Laboratories for nearly $1.1 billion.


M&A, Sawai Pharmaceutical, Upsher-Smith, generic, Acova, mergers and acquisitions, pharmaceuticals,

LSIPR